These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 20718162
1. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. Trakarnvanich T, Chalapipat O, Disthabanchong S, Kurathong S, Praditpornsilpa K, Stitchantrakul W, Chailurkit LO. J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162 [Abstract] [Full Text] [Related]
2. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Zisman AL, Hristova M, Ho LT, Sprague SM. Am J Nephrol; 2007 Aug; 27(1):36-43. PubMed ID: 17215573 [Abstract] [Full Text] [Related]
3. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. Blair D, Byham-Gray L, Lewis E, McCaffrey S. J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303 [Abstract] [Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
5. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW. Nephron Clin Pract; 2007 Nov; 105(3):c132-8. PubMed ID: 17228173 [Abstract] [Full Text] [Related]
6. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Leventis P, Kiely PD. Scand J Rheumatol; 2009 Nov; 38(2):149-53. PubMed ID: 18991184 [Abstract] [Full Text] [Related]
7. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial. Thimachai P, Supasyndh O, Chaiprasert A, Satirapoj B. J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985 [Abstract] [Full Text] [Related]
11. Vitamin D status of chronic kidney disease patients living in a sunny country. Cuppari L, Carvalho AB, Draibe SA. J Ren Nutr; 2008 Sep; 18(5):408-14. PubMed ID: 18721735 [Abstract] [Full Text] [Related]
12. On-line haemodiafiltration improves response to calcifediol treatment. Pérez-García R, Albalate M, de Sequera P, Alcázar R, Puerta M, Ortega M, Corchete E. Nefrologia; 2012 Jul 17; 32(4):459-66. PubMed ID: 22652556 [Abstract] [Full Text] [Related]
18. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. Nephrol Dial Transplant; 2008 Nov 17; 23(11):3670-6. PubMed ID: 18579534 [Abstract] [Full Text] [Related]
19. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial. Wetmore JB, Kimber C, Mahnken JD, Stubbs JR. Br J Nutr; 2016 Dec 17; 116(12):2074-2081. PubMed ID: 28065190 [Abstract] [Full Text] [Related]
20. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Jean G, Souberbielle JC, Chazot C. Nephrol Dial Transplant; 2009 Dec 17; 24(12):3799-805. PubMed ID: 19622574 [Abstract] [Full Text] [Related] Page: [Next] [New Search]